Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management

Abstract

Given that polypharmacy and the chronic use of multiple drugs are a reality for older patients with cancer and polymorbidities, outcome data need to be generated and motivations/incentives provided for physicians to optimize safe and effective supportive oncologic therapeutics.